Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Yotaro Iino"'
Autor:
Tsubasa Ishikawa, Kenichiro Okimoto, Tomoaki Matsumura, Sadahisa Ogasawara, Yoshihiro Fukuda, Yoshio Kitsukawa, Yuya Yokoyama, Kengo Kanayama, Naoki Akizue, Yotaro Iino, Yuki Ohta, Hideaki Ishigami, Takashi Taida, Shin Tsuchiya, Keiko Saito, Hidehiro Kamezaki, Akitoshi Kobayashi, Yasuharu Kikuchi, Minoru Tada, Yuki Shiko, Yoshihito Ozawa, Jun Kato, Taketo Yamaguchi, Naoya Kato
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract This study aimed to investigate the lesion and endoscopist factors associated with unintentional endoscopic piecemeal mucosal resection (uniEPMR) of colorectal lesions ≥ 10 mm. uniEPMR was defined from the medical record as anything other
Externí odkaz:
https://doaj.org/article/46e52963e13242139dc770f49feb8ab5
Autor:
Takashi Taida, Yuki Ohta, Jun Kato, Sadahisa Ogasawara, Yuhei Ohyama, Yukiyo Mamiya, Hayato Nakazawa, Ryosuke Horio, Chihiro Goto, Satsuki Takahashi, Akane Kurosugi, Michiko Sonoda, Wataru Shiratori, Tatsuya Kaneko, Yuya Yokoyama, Naoki Akizue, Yotaro Iino, Junichiro Kumagai, Hideaki Ishigami, Hirotaka Koseki, Kenichiro Okimoto, Keiko Saito, Masaya Saito, Tomoaki Matsumura, Tomoo Nakagawa, Shinichiro Okabe, Hirofumi Saito, Kazuki Kato, Hirotsugu Uehara, Hideaki Mizumoto, Yoshihiro Koma, Ryosaku Azemoto, Kenji Ito, Hidehiro Kamezaki, Yoshifumi Mandai, Yoshio Masuya, Yoshihiro Fukuda, Yoshio Kitsukawa, Haruhisa Shimura, Toshio Tsuyuguchi, Naoya Kato
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract Many molecular targeted agents, including biologics, have emerged for inflammatory bowel diseases (IBD), but their high prices have prevented their widespread use. This study aimed to reveal the changes in patient characteristics and the the
Externí odkaz:
https://doaj.org/article/cb9d3bf198234cee83634445e2631f17
Autor:
Sae Yumita, Sadahisa Ogasawara, Miyuki Nakagawa, Susumu Maruta, Tomomi Okubo, Norio Itokawa, Yotaro Iino, Masamichi Obu, Yuki Haga, Atsuyoshi Seki, Tadayoshi Kogure, Takamasa Ishino, Keita Ogawa, Kisako Fujiwara, Terunao Iwanaga, Naoto Fujita, Takafumi Sakuma, Ryuta Kojima, Hiroaki Kanzaki, Keisuke Koroki, Masanori Inoue, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Naoya Kanogawa, Tomoko Saito, Takayuki Kondo, Ryo Nakagawa, Shingo Nakamoto, Ryosuke Muroyama, Tetsuhiro Chiba, Ei Itobayashi, Masanori Atsukawa, Yoshihiro Koma, Ryosaku Azemoto, Kenji Ito, Hideaki Mizumoto, Jun Kato, Naoya Kato
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Hyperprogressive disease (HPD) is a phenomenon with greatly accelerated tumor growth and clinical deterioration rates compared to pre-therapy, in patients treated with immune checkpoint inhibitors (ICI). The aim of this study is t
Externí odkaz:
https://doaj.org/article/e6438030eab2449d8f1c4414595c6e53
Autor:
Naoya Kanogawa, Sadahisa Ogasawara, Susumu Maruta, Yotaro Iino, Masamichi Obu, Takamasa Ishino, Keita Ogawa, Sae Yumita, Terunao Iwanaga, Hidemi Unozawa, Miyuki Nakagawa, Kisako Fujiwara, Takafumi Sakuma, Naoto Fujita, Ryuta Kojima, Hiroaki Kanzaki, Keisuke Koroki, Kazufumi Kobayashi, Masanori Inoue, Soichiro Kiyono, Masato Nakamura, Takayuki Kondo, Tomoko Saito, Ryo Nakagawa, Shingo Nakamoto, Ryosuke Muroyama, Tetsuhiro Chiba, Ei Itobayashi, Yoshihiro Koma, Ryosaku Azemoto, Jun Kato, Naoya Kato
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Purpose Ramucirumab was shown to be effective as a second-line treatment after sorafenib in patients with advanced hepatocellular carcinoma (HCC) with alpha-fetoprotein levels > 400 ng/mL in a worldwide phase 3 trial. Ramucirumab is used in
Externí odkaz:
https://doaj.org/article/ec4cc9154a2f40df8dcaa61493fe4d89
Autor:
Keisuke Koroki, Naoya Kanogawa, Susumu Maruta, Sadahisa Ogasawara, Yotaro Iino, Masamichi Obu, Tomomi Okubo, Norio Itokawa, Takahiro Maeda, Masanori Inoue, Yuki Haga, Atsuyoshi Seki, Shinichiro Okabe, Yoshihiro Koma, Ryosaku Azemoto, Masanori Atsukawa, Ei Itobayashi, Kenji Ito, Nobuyuki Sugiura, Hideaki Mizumoto, Hidemi Unozawa, Terunao Iwanaga, Takafumi Sakuma, Naoto Fujita, Hiroaki Kanzaki, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Tomoko Saito, Takayuki Kondo, Eiichiro Suzuki, Yoshihiko Ooka, Shingo Nakamoto, Akinobu Tawada, Tetsuhiro Chiba, Makoto Arai, Tatsuo Kanda, Hitoshi Maruyama, Jun Kato, Naoya Kato
Publikováno v:
Liver Cancer, Pp 1-12 (2021)
Background: There is no standard posttreatment for patients with advanced hepatocellular carcinoma (HCC) in whom lenvatinib therapy has failed. This study aimed to investigate rates of migration to posttreatment after lenvatinib and to explore candid
Externí odkaz:
https://doaj.org/article/4cc7f3182bb149d4bf42ff53cc56445b
Autor:
Koji Takahashi, Hiroshi Ohyama, Yuichi Takiguchi, Yu Sekine, Shodai Toyama, Nana Yamada, Chihei Sugihara, Motoyasu Kan, Mayu Ouchi, Hiroki Nagashima, Yotaro Iino, Yuko Kusakabe, Kohichiroh Okitsu, Izumi Ohno, Naoya Kato
Publikováno v:
Medicina, Vol 59, Iss 4, p 795 (2023)
Background and objectives: The safety of electrohydraulic lithotripsy (EHL) in older adults remains unclear. We aimed to investigate the efficacy and safety of EHL using peroral cholangioscopy (POCS) under endoscopic retrograde cholangiopancreatograp
Externí odkaz:
https://doaj.org/article/d133a9e9075f461cb4413e7b79aeb47a
Autor:
Yotaro Iino, Hitoshi Maruyama, Rintaro Mikata, Shin Yasui, Keisuke Koroki, Hiroki Nagashima, Masami Awatsu, Ayako Shingyoji, Yuko Kusakabe, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Hiroshi Ohyama, Harutoshi Sugiyama, Yuji Sakai, Tetsuhiro Chiba, Jun Kato, Toshio Tsuyuguchi, Naoya Kato
Publikováno v:
Diagnostics, Vol 11, Iss 3, p 498 (2021)
Background: To investigate the efficacy of two-dimensional shear wave elastography (2D-SWE) for the diagnosis of pancreatic mass lesions. Methods: This ethics committee–approved cross-sectional study included 52 patients with histologically-proven
Externí odkaz:
https://doaj.org/article/1c5e546e78c04d85b60af41aad2aa6c2
Autor:
Junichiro Kumagai, Takashi Taida, Sadahisa Ogasawara, Tomoo Nakagawa, Yotaro Iino, Ayako Shingyoji, Kentaro Ishikawa, Naoki Akizue, Mutsumi Yamato, Koji Takahashi, Yuki Ohta, Shinsaku Hamanaka, Kenichiro Okimoto, Masato Nakamura, Hiroshi Ohyama, Keiko Saito, Yuko Kusakabe, Daisuke Maruoka, Shin Yasui, Tomoaki Matsumura, Harutoshi Sugiyama, Yuji Sakai, Rintaro Mikata, Makoto Arai, Tatsuro Katsuno, Toshio Tsuyuguchi, Naoya Kato
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0209352 (2018)
BACKGROUND:In Western countries, most patients with primary sclerosing cholangitis (PSC) have concurrent ulcerative colitis (UC). The number of patients with UC in East Asia has increased markedly over the past two decades. However, current clinical
Externí odkaz:
https://doaj.org/article/709e30ce20f34c9189c56221bc9a5fc7
Autor:
Miyuki Nakagawa, Masanori Inoue, Sadahisa Ogasawara, Susumu Maruta, Tomomi Okubo, Norio Itokawa, Yotaro Iino, Masamichi Obu, Yuki Haga, Atsuyoshi Seki, Yasuharu Kikuchi, Tadayoshi Kogure, Sae Yumita, Takamasa Ishino, Keita Ogawa, Kisako Fujiwara, Terunao Iwanaga, Naoto Fujita, Takafumi Sakuma, Ryuta Kojima, Hiroaki Kanzaki, Keisuke Koroki, Takashi Taida, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Naoya Kanogawa, Takayuki Kondo, Ryo Nakagawa, Shingo Nakamoto, Ryosuke Muroyama, Tetsuhiro Chiba, Ei Itobayashi, Masanori Atsukawa, Yoshihiro Koma, Ryosaku Azemoto, Kenji Ito, Hideaki Mizumoto, Masami Shinozaki, Jun Kato, Naoya Kato
Publikováno v:
Cancer. 129:590-599
Although the efficacy of atezolizumab has been demonstrated in randomized controlled trials, its long-term efficacy and association with adverse events in real-world practice are unknown. This study was designed to shed light on these issues.In this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b54ec0aa54455ab40bab1036ea7a7b81
https://doi.org/10.1002/cncr.34559
https://doi.org/10.1002/cncr.34559
Autor:
Koji Takahashi, Hiroshi Ohyama, Hiroki Nagashima, Yotaro Iino, Yuko Kusakabe, Kohichiroh Okitsu, Izumi Ohno, Yuichi Takiguchi, Naoya Kato
Publikováno v:
Clinical Journal of Gastroenterology. 15:988-993
A 77-year-old woman with obstructive jaundice due to pancreatic head tumor was admitted to our hospital for biliary drainage. Transpapillary biliary drainage was attempted using endoscopic retrograde cholangiopancreatography; however, the catheter co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::915ca9a57b0a16e70afce37196cb52bc
https://doi.org/10.1007/s12328-022-01659-9
https://doi.org/10.1007/s12328-022-01659-9